Saturday, 31 October 2026European Markets

VOLUE Stock 9.13% Up On Thursday

Loading stream...

(VIANEWS) - The Market ended the session with VOLUE (VOLUE.OL) rising 9.13% to kr22.70 on Thursday while Oslo Børs Benchmark Index_GI rose 0.28% to kr1,255.60.

VOLUE's last close was kr20.80, 37.82% below its 52-week high of kr33.45.

About VOLUE

Volue ASA, together with its subsidiaries, engages in the provision of software and technology solutions for the energy, power grid, and infrastructure markets worldwide. It operates in three segments: Energy, Power Grid, and Infrastructure. The Energy segment offers software solutions and consulting services related to forecasting and optimization of the different energy markets that enables end-to-end optimization of the green energy value-chain. The Power Grid segment provides software solutions and consulting services that enables power distributors to support electrification of society by unlocking flexibility and digital management of the power grid. The Infrastructure segment offers software solutions and consulting services that delivers flexible solutions for digital water management. This segment is also involved in the automation of processes and machines for the construction industry. Volue ASA was incorporated in 2019 and is headquartered in Oslo, Norway. Volue ASA operates as a subsidiary of Arendals Fossekompani ASA.

Earnings Per Share

As for profitability, VOLUE has a trailing twelve months EPS of kr0.35.

PE Ratio

VOLUE has a trailing twelve months price to earnings ratio of 64.86. Meaning, the purchaser of the share is investing kr64.86 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.57%.

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is a negative 14.3% and a negative 4.3%, respectively.

Yearly Top and Bottom Value

VOLUE's stock is valued at kr22.70 at 22:34 EST, way below its 52-week high of kr33.45 and way above its 52-week low of kr16.00.

Sales Growth

VOLUE's sales growth is 31.5% for the current quarter and 21.5% for the next.

More news about VOLUE (VOLUE.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com